Oncogenic role of PDK4 in human colon cancer cells
- PMID: 28208156
- PMCID: PMC5379150
- DOI: 10.1038/bjc.2017.38
Oncogenic role of PDK4 in human colon cancer cells
Abstract
Background: Cancer cells maintain high rates of glycolysis. Pyruvate dehydrogenase kinases (PDK) contribute to this phenomenon, which favours apoptosis resistance and cellular transformation. We previously reported upregulation of PDK4 in normal mucosa of colorectal cancer (CRC) patients compared with controls and in preneoplastic intestine of our mouse model. Decreased methylation of four consecutive PDK4 CpGs was observed in normal mucosa of patients. Although other members of the PDK family have been investigated for transformation potential, PDK4 has not been extensively studied.
Methods: PDK4 methylation in blood of CRC patients and controls was evaluated by pyrosequencing. PDK4 expression in human colon carcinoma cells was down-regulated by RNAi. Cellular migration and invasion, apoptosis and qRT-PCR of key genes were assessed.
Results: Pyrosequencing revealed decreased methylation of the same four consecutive CpGs in the blood of patients compared with controls. Cellular migration and invasion were reduced and apoptosis was increased following transient or stable inhibition of PDK4. Expression of vimentin, HIF-1 and VEGFA was reduced.
Conclusions: These studies demonstrate the involvement of PDK4 in transformation. Methylation assessment of PDK4 in the blood may be useful for non-invasive CRC detection. PDK4 should be considered as a target for development of anticancer strategies and therapies.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Genes with aberrant expression in murine preneoplastic intestine show epigenetic and expression changes in normal mucosa of colon cancer patients.Cancer Prev Res (Phila). 2013 Nov;6(11):1171-81. doi: 10.1158/1940-6207.CAPR-13-0198. Epub 2013 Oct 29. Cancer Prev Res (Phila). 2013. PMID: 24169962
-
Up-regulation of NEK2 by microRNA-128 methylation is associated with poor prognosis in colorectal cancer.Ann Surg Oncol. 2014 Jan;21(1):205-12. doi: 10.1245/s10434-013-3264-3. Epub 2013 Sep 18. Ann Surg Oncol. 2014. PMID: 24046120
-
Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer.Carcinogenesis. 2013 Nov;34(11):2548-57. doi: 10.1093/carcin/bgt282. Epub 2013 Sep 3. Carcinogenesis. 2013. PMID: 24001454
-
The microRNA-182-PDK4 axis regulates lung tumorigenesis by modulating pyruvate dehydrogenase and lipogenesis.Oncogene. 2017 Feb 16;36(7):989-998. doi: 10.1038/onc.2016.265. Epub 2016 Sep 19. Oncogene. 2017. PMID: 27641336
-
The Implications of PDK1-4 on Tumor Energy Metabolism, Aggressiveness and Therapy Resistance.Front Oncol. 2020 Dec 15;10:583217. doi: 10.3389/fonc.2020.583217. eCollection 2020. Front Oncol. 2020. PMID: 33384955 Free PMC article. Review.
Cited by
-
Targeting Mitochondrial OXPHOS and Their Regulatory Signals in Prostate Cancers.Int J Mol Sci. 2021 Dec 14;22(24):13435. doi: 10.3390/ijms222413435. Int J Mol Sci. 2021. PMID: 34948229 Free PMC article. Review.
-
PDK4-dependent hypercatabolism and lactate production of senescent cells promotes cancer malignancy.Nat Metab. 2023 Nov;5(11):1887-1910. doi: 10.1038/s42255-023-00912-w. Epub 2023 Oct 30. Nat Metab. 2023. PMID: 37903887 Free PMC article.
-
High hepatic expression of PDK4 improves survival upon multimodal treatment of colorectal liver metastases.Br J Cancer. 2019 Apr;120(7):675-688. doi: 10.1038/s41416-019-0406-9. Epub 2019 Feb 27. Br J Cancer. 2019. PMID: 30808993 Free PMC article.
-
PDK4 drives metabolic alterations and muscle atrophy in cancer cachexia.FASEB J. 2019 Jun;33(6):7778-7790. doi: 10.1096/fj.201802799R. Epub 2019 Mar 20. FASEB J. 2019. PMID: 30894018 Free PMC article.
-
Immunity Depletion, Telomere Imbalance, and Cancer-Associated Metabolism Pathway Aberrations in Intestinal Mucosa upon Short-Term Caloric Restriction.Cancers (Basel). 2021 Jun 25;13(13):3180. doi: 10.3390/cancers13133180. Cancers (Basel). 2021. PMID: 34202278 Free PMC article.
References
-
- Barrès R, Yan J, Egan B, Treebak JT, Rasmussen M, Fritz T, Caidahl K, Krook A, O'Gorman DJ, Zierath JR (2012) Acute exercise remodels promoter methylation in human skeletal muscle. Cell Metab 15: 405–411. - PubMed
-
- Barrès R, Kirchner H, Rasmussen M, Yan J, Kantor FR, Krook A, Näslund E, Zierath JR (2013) Weight loss after gastric bypass surgery in human obesity remodels promoter methylation. Cell Rep 3: 1020–1027. - PubMed
-
- Blouin JM, Penot G, Collinet M, Nacfer M, Forest C, Laurent-Puig P, Coumoul X, Barouki R, Benelli C, Bortoli S (2011) Butyrate elicits a metabolic switch in human colon cancer cells by targeting the pyruvate dehydrogenase complex. Int J Cancer 128: 2591–2601. - PubMed
-
- Bohl SR, Claus R, Dolnik A, Schlenk RF, Döhner K, Hackanson B, Döhner H, Lübbert M, Bullinger L (2013) Decitabine response associated gene expression patterns in acute myeloid leukemia (AML). Blood 122: 3756.
-
- Bonnet S, Archer SL, Allalunis-Turner J, Haromy A, Beaulieu C, Thompson R, Lee CT, Lopaschuk GD, Puttagunta L, Bonnet S, Harry G, Hashimoto K, Porter CJ, Andrade MA, Thebaud B, Michelakis ED (2007) A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 11: 37–51. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
